Jadenu Granule
Product Images NDC 0078-0713

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Jadenu (NDC 0078-0713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Deferasirox Structural Formula. (Jadenu 01)

Deferasirox Structural Formula. (Jadenu 01)
This text is not available for a useful description, as it only contains the chemical symbol for hydroxide (OH) and does not provide any context or additional information.*
FDA Label Image

Figure 1. Changes In Liver Iron Concentration And Serum Ferritin Following Jadenu (5 30 mg/kg Per Day) In Study 1. (Jadenu 02)

Figure 1. Changes In Liver Iron Concentration And Serum Ferritin Following Jadenu (5 30 mg/kg Per Day) In Study 1. (Jadenu 02)
FDA Label Image

Principal Display Panel – Package Label – 90 mg (Jadenu 03)

Principal Display Panel – Package Label – 90 mg (Jadenu 03)
FDA Label Image

Principal Display Panel – Package Label – 180 mg (Jadenu 04)

Principal Display Panel – Package Label – 180 mg (Jadenu 04)
FDA Label Image

Principal Display Panel – Package Label – 360 mg (Jadenu 05)

Principal Display Panel – Package Label – 360 mg (Jadenu 05)
FDA Label Image

Principal Display Panel – Package Label – 90 mg Sprinkle (Jadenu Sprinkle 06)

Principal Display Panel – Package Label – 90 mg Sprinkle (Jadenu Sprinkle 06)
Patient instructions for administering Jadenu Sprinkle (deferasirox) oral granules are provided. The instructions include shaking the sachet, tearing it open, pouring the contents onto soft food, and consuming the entire dose immediately. The medication is contained in a package which contains 30 sachets of oral granules. The text also includes the medication's name and manufacturer.*
FDA Label Image

Principal Display Panel – Package Label – 180 mg Sprinkle (Jadenu Sprinkle 07)

Principal Display Panel – Package Label – 180 mg Sprinkle (Jadenu Sprinkle 07)
FDA Label Image

Principal Display Panel – Package Label – 360 mg Sprinkle (Jadenu Sprinkle 08)

Principal Display Panel – Package Label – 360 mg Sprinkle (Jadenu Sprinkle 08)
This is a mixed text indicating some kind of medication. The text mentions the name of medication "JadenuSprinkle", which contains deferasirox oral granules and some instructions to use. The manufacturer of the medication is Novartis. Some of the text is not readable due to errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.